Entering text into the input field will update the search result below

Alvotech, Bioventure get approval for Humira biosimilar in Saudi Arabia

Jan. 24, 2023 5:02 AM ETAlvotech (ALVO) Stock, ABBV StockBy: Ravikash Bakolia, SA News Editor

APPROVED Rubber Stamp On Yellow Background 3D Rendering

GOCMEN

  • Alvotech (NASDAQ:ALVO) and Bioventure said that the Saudi Food & Drug Authority (SFDA) approved the manufacturing and distribution of AVT02, a biosimilar to AbbVie's (NYSE:ABBV) blockbuster drug Humira (adalimumab).
  • The drug is indicated for to treat rheumatoid arthritis

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ABBV
--
ALVO
--